The effect of Psidium guajava Leaves' extract for mild and asymptomatic corona virus Disease-19.
Ontology highlight
ABSTRACT: COVID-19 is an emerging disease that attacks the respiratory and systemic systems. Various treatments have been used for COVID-19, but no antiviral agents seemed to be efficacious. Many medicinal plants are commonly used for viral infections in Indonesia, including the guajava leaf. The study aimed to determine the effects of Psidium guajava extract supplementation on inflammation markers of asymptomatic and mild COVID-19 patients. The conversion time of PCR results was also evaluated. This study was an experimental, single-blinded, randomized clinical trial (ClinicalTrials.gov: NCT04810728) comparing the efficacy of P. guajava extract at the dose of 1000 mg/8h on top of standard treatment with the standard treatment only for asymptomatic and mild COVID-19 subjects. The prima
SUBMITTER: Heppy F
PROVIDER: S-EPMC9988311 | biostudies-literature | 2023 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA